Skip to main content
  • Jon Juliano Headshot-$3.4-million-grant

    Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa

    Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Read more

  • August- Grants and Funding

    Department of Medicine Grants & Funding: August 1 – August 31, 2022

    Division of Rheumatology, Allergy and Immunology Amanda Nelson, MD, MSCR, RhMSUS, received, a 5-Year, $3.4M NIH grant to investigate intestinal permeability in multi-joint osteoarthritis Saira Sheikh, MD, and team receive $500K NIH U01 “Innovation Award” from FDA’s Office of Minority Health & Health Equity, to advance diversity and representation in lupus. Amanda Nelson, MD, … Read more

  • Jonathan Juliano, MD, MSPH

    Juliano Honored With IDSA Designation

    Jonathan J. Juliano, MD, MSPH, has been named Fellow by the Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society. Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished physicians and scientists from the United States and around the world who have achieved professiona … Read more

  • kovarova-TB-Study.jpg

    Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

    In 2020, more than 1.5 million people around the world died of tuberculosis (TB), marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments. To address that problem, scientists with the UNC Department of Medicine, the UNC Institute for Global Health and Infectious Diseases, and the Internatio … Read more

  • waltmann-meshnick-scaled-e1656101391554-1024x793

    Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

    Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread SP-resistant malaria. Compell … Read more

  • ross-boyce-cdc-renews-funding

    CDC renews five-year funding for vector-borne disease threats

    The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, an … Read more

  • July- Grants and Funding

    Department of Medicine Grants & Funding: July 1 – July 31, 2022

    Division of Hematology Patrick Ellsworth, MD, received a grant for his project titled “Mechanistic Investigation of Factor IX/Ixa Synergy with Emicizumab” from Novo Nordisk “Access to Insight” Division of Nephrology and Hypertension Gang Xi, PhD, and Prabir Roy-Chaudhury, MD, PhD, FRCP(Edin), were recently awarded a $2.7 million grant by the National Institute of Diabetes and Dig … Read more

  • Integrating HIV Prevention into Rural Clinics

    In 2019, North Carolina ranked 6th for new HIV diagnoses, with a concentrated epidemic among young sexual and gender minorities, including men who have sex with men and transgender women. In North Carolina, two-thirds of all new adult or adolescent HIV infections were among African Americans/Blacks. With a grant from the National Institutes of Health, Sarah Rutstein, MD, PhD, an … Read more

  • COVID-19 Cases Increasing, New Omicron Subvariant, Monkeypox Testing: Dr. David Wohl Provides Insight

    David Wohl, MD, professor of medicine in the Division of Infectious Diseases, is featured in the below local and national media articles.  ‘COVID is not done with us’: Why is the BA.5 COVID-19 variant so contagious? – Dr. David Wohl (MSN) ‘Then it was like nope, mask on’: Masks return to Durham dance studio amid latest omicron subvariant – Dr. David Wohl (WTVD) Why is the COVID: … Read more

  • Dr. Stanley Lemon and Other UNC Scientists Discover Key to Hepatitis A Virus Replication, Show Drug Effectiveness

    With no current treatments for hepatitis A, Stanley M. Lemon, MD, a professor in the Division of Infectious Diseases, and other UNC scientists discovered how a protein and enzymes interact to allow hepatitis A virus to replicate, and they used a known drug to stop viral replication in an animal model. The viral replication cycle is crucial for a virus to spread inside the body an … Read more

  • June- Grants and Funding

    Department of Medicine Grants & Funding: June 1 – June 30, 2022

    Division of Infectious Diseases Becky White, MD, MPH, was awarded $200,000 by the Looking Forward funding program to better understand testing and vaccination rates within a large jail in Wake County, N.C., as well as when the survey respondents return to their home communities. Tessa Andermann, MD, MPH, received a $30,000 pilot award from the Center for Gastrointestinal Biology … Read more

  • Chris Evans earns 2022 Claude Paoloni Preceptor of the Year Award

    Chris Evans, DNP, MSN, a research instructor and assistant professor of clinical education in the Division of Infectious Diseases, was one of three recipients of the 2022 Claude Paoloni Preceptor of the Year Award! The Claude Paoloni Preceptor of the Year Award recognizes preceptors for outstanding contributions to the educational development of future pharmacists. These individu … Read more